Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer (update): a systematic review and economic evaulation

C. Main, L. Ginnelly, S. Griffin, G. Norman, M. Barbieri, L. Mather, D. Stark, S. Palmer, R. Riemsma

Research output: Working paper

Original languageEnglish
Publication statusPublished - 2006

Cite this